Cite
HARVARD Citation
Schloer, S. et al. (2020). Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Emerging microbes & infections. 9 (1), pp. 2245-2255. [Online].